Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Mechanisms of immune-mediated demyelinating disease of the central nervous system.

× No keyword cloud information.

52 in total

1. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

Authors: D C Wraith; D E Smilek; D J Mitchell; L Steinman; H O McDevitt
Journal: Cell Date: 1989-10-20 Impact factor: 41.582

2. Tumor necrosis factor mediates myelin damage in organotypic cultures of nervous tissue.

Authors: K Selmaj; C S Raine
Journal: Ann N Y Acad Sci Date: 1988 Impact factor: 5.691

3. Inhibition of chronic relapsing experimental allergic encephalomyelitis in the mouse by the alkyl-lysophospholipid ET-18-OCH3.

Authors: D Baker; J K O'Neill; S Amor; M A Khamashta; J L Turk
Journal: Int J Immunopharmacol Date: 1991

4. Major histocompatibility complex molecule expression in the human central nervous system: immunohistochemical analysis of 40 patients.

Authors: R A Sobel; M B Ames
Journal: J Neuropathol Exp Neurol Date: 1988-01 Impact factor: 3.685

5. Degradation of human myelin in vitro by leucocytes from patients with multiple sclerosis.

Authors: S J Owen; C M Watson; A N Davison
Journal: Clin Exp Immunol Date: 1990-10 Impact factor: 4.330

6. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.

Authors: H J Schluesener; R A Sobel; C Linington; H L Weiner
Journal: J Immunol Date: 1987-12-15 Impact factor: 5.422

7. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system.

Authors: R A Sobel; M E Mitchell; G Fondren
Journal: Am J Pathol Date: 1990-06 Impact factor: 4.307

8. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.

Authors: A S Bellamy; V L Calder; M Feldmann; A N Davison
Journal: Clin Exp Immunol Date: 1985-08 Impact factor: 4.330

9. Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice.

Authors: F Mokhtarian; D E McFarlin; C S Raine
Journal: Nature Date: 1984 May 24-30 Impact factor: 49.962

10. Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction.

Authors: H M Wisniewski; B R Bloom
Journal: J Exp Med Date: 1975-02-01 Impact factor: 14.307

3 in total

Review 1. Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

Authors: A Rouleau; V Dimitriadou; M D Trung Tuong; G F Newlands; H R Miller; J C Schwartz; M Garbarg
Journal: J Neural Transm (Vienna) Date: 1997 Impact factor: 3.575

2. Control of immune-mediated disease of the central nervous system requires the use of a neuroactive agent: elucidation by the action of mitoxantrone.

Authors: D Baker; J K O'Neill; A N Davison; J L Turk
Journal: Clin Exp Immunol Date: 1992-10 Impact factor: 4.330

3. Cerebrospinal fluid concentrations of the complement MAC inhibitor CD59 in multiple sclerosis and patients with other neurological disorders.

Authors: J Roddy; I Clark; B L Hazleman; D A Compston; N J Scolding
Journal: J Neurol Date: 1994-08 Impact factor: 4.849

3 in total